These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34634315)

  • 1. Altered HDL proteome predicts incident CVD in chronic kidney disease patients.
    Shao B; Mathew AV; Thornock C; Pennathur S;
    J Lipid Res; 2021; 62():100135. PubMed ID: 34634315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.
    Shao B; Afshinnia F; Mathew AV; Ronsein GE; Thornock C; Irwin AD; Kansal M; Rao PS; Dobre M; Al-Kindi S; Weir MR; Go A; He J; Chen J; Feldman H; Bornfeldt KE; Pennathur S;
    J Lipid Res; 2023 Jun; 64(6):100381. PubMed ID: 37100172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.
    Ronsein GE; Reyes-Soffer G; He Y; Oda M; Ginsberg H; Heinecke JW
    Mol Cell Proteomics; 2016 Mar; 15(3):1083-93. PubMed ID: 26667175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of paraoxonase 1 (PON1) on HDL
    Miljkovic M; Stefanovic A; Vekic J; Zeljkovic A; Gojkovic T; Simic-Ogrizovic S; Bogavac-Stanojevic N; Cerne D; Ilic J; Stefanovic I; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Kotur-Stevuljevic J
    Clin Biochem; 2018 Sep; 60():52-58. PubMed ID: 30130521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
    Samouilidou E; Bountou E; Papandroulaki F; Papamanolis M; Papakostas D; Grapsa E
    Ther Apher Dial; 2018 Aug; 22(4):325-331. PubMed ID: 29368426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
    Kennedy DJ; Tang WH; Fan Y; Wu Y; Mann S; Pepoy M; Hazen SL
    J Am Heart Assoc; 2013 Apr; 2(2):e000104. PubMed ID: 23557751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response.
    Kumon Y; Nakauchi Y; Kidawara K; Fukushima M; Kobayashi S; Ikeda Y; Suehiro T; Hashimoto K; Sipe JD
    Scand J Immunol; 1998 Oct; 48(4):419-24. PubMed ID: 9790313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
    Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
    Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD.
    Stadler JT; Bärnthaler T; Borenich A; Emrich IE; Habisch H; Rani A; Holzer M; Madl T; Heine GH; Marsche G
    J Lipid Res; 2024 Sep; 65(9):100624. PubMed ID: 39154733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum paraoxonase activity decreases in rheumatoid arthritis.
    Tanimoto N; Kumon Y; Suehiro T; Ohkubo S; Ikeda Y; Nishiya K; Hashimoto K
    Life Sci; 2003 May; 72(25):2877-85. PubMed ID: 12697270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
    Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
    Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes.
    Shao B; Snell-Bergeon JK; Pyle LL; Thomas KE; de Boer IH; Kothari V; Segrest J; Davidson WS; Bornfeldt KE; Heinecke JW
    J Lipid Res; 2022 Apr; 63(4):100196. PubMed ID: 35300983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoproteins and the Kidney.
    Strazzella A; Ossoli A; Calabresi L
    Cells; 2021 Mar; 10(4):. PubMed ID: 33807271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.